Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates
Phase 1
Not yet recruiting
- Conditions
- Drug Interaction
- Interventions
- Drug: Part 1Drug: Part 2
- First Posted Date
- 2025-04-16
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Harmony Biosciences Management, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT06930872
- Locations
- 🇦🇺
CMAX Clinical Research, Adelaide, South Australia, Australia
A Study of Pitolisant in Patients with Prader-Willi Syndrome
Phase 3
Recruiting
- Conditions
- Prader-Willi Syndrome
- Interventions
- Other: Placebo tablet
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Harmony Biosciences Management, Inc.
- Target Recruit Count
- 134
- Registration Number
- NCT06366464
- Locations
- 🇺🇸
Santa Monica Clinical Trials, Los Angeles, California, United States
🇺🇸Center of Excellence in Diabetes and Endocrinology, Sacramento, California, United States
🇺🇸Colorado Children's Hospital, Aurora, Colorado, United States
Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1
Phase 2
Completed
- Conditions
- Excessive Daytime SleepinessMyotonic Dystrophy 1
- Interventions
- Drug: Placebo oral tablet
- First Posted Date
- 2021-05-14
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Harmony Biosciences Management, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04886518
- Locations
- 🇨🇦
Hôpital de Chicoutimi, Chicoutimi, Quebec, Canada
🇨🇦The Ottawa Hospital, Ottawa, Ontario, Canada
🇺🇸UCI Center for Clinical Research, Irvine, California, United States
© Copyright 2025. All Rights Reserved by MedPath